Hims & Hers Reports Mixed Q1 2026 Results Amid Strategic Pivot
Event summary
- Hims & Hers reported a 4% year-over-year revenue increase to $608.1 million in Q1 2026, but net loss widened to $92.1 million from a $49.5 million profit in Q1 2025.
- Subscriber base grew by 9% to 2.6 million, while monthly revenue per average subscriber declined by 6% to $80.
- Company plans to transition to annual shareholder letters while maintaining quarterly earnings calls.
- Strategic pivot expanded branded GLP-1 products, showing early demand signals.
- Full-year 2026 revenue guidance set at $2.8 billion to $3.0 billion, with Adjusted EBITDA margin expected between 10% and 12%.
The big picture
Hims & Hers is navigating a strategic pivot to expand its GLP-1 product offerings amid a competitive health and wellness market. The company's ability to balance growth with profitability will be crucial as it aims to become the world's largest consumer health platform. The proposed acquisition of Eucalyptus adds another layer of complexity to its strategic roadmap.
What we're watching
- Execution Risk
- Whether Hims & Hers can sustain growth while managing increased operational costs and maintaining subscriber retention.
- Market Expansion
- The pace at which the company can successfully expand into new categories and international markets.
- Integration Challenges
- How the proposed acquisition of Eucalyptus will impact Hims & Hers' strategic goals and financial performance.
Related topics